The measurement of anti-SARS-CoV-2 neutralizing antibodies via fully automated, fast, high-throughput, and relatively inexpensive immunoassays is now possible and should thus be widely encouraged before COVID-19 vaccination. Their post-vaccine assessment may also help to solve the dilemma on the optimal dose interval of COVID-19 vaccine administration since the period from the first vaccine dose to the booster could be specifically tailored according to the serum levels of anti-SARS-CoV-2 neutralizing antibodies, while consideration of administering a third dose could be made in older and/or immunocompromised subjects, who often display insufficient serologic response to the administration of the first two doses.

Serological assessment is advisable before COVID-19 vaccination

Lippi, Giuseppe
;
2022

Abstract

The measurement of anti-SARS-CoV-2 neutralizing antibodies via fully automated, fast, high-throughput, and relatively inexpensive immunoassays is now possible and should thus be widely encouraged before COVID-19 vaccination. Their post-vaccine assessment may also help to solve the dilemma on the optimal dose interval of COVID-19 vaccine administration since the period from the first vaccine dose to the booster could be specifically tailored according to the serum levels of anti-SARS-CoV-2 neutralizing antibodies, while consideration of administering a third dose could be made in older and/or immunocompromised subjects, who often display insufficient serologic response to the administration of the first two doses.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11562/1053216
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact